Optimist Retirement Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
93,529
+311
+0.3% +$8.13K 0.87% 35
2026
Q1
$2.62M Buy
93,218
+56,204
+152% +$1.5M 1.15% 21
2025
Q4
$922K Sell
37,014
-50,690
-58% -$1.28M 0.42% 40
2025
Q3
$2.23M Buy
87,704
+2,832
+3% +$69.9K 1.01% 33
2025
Q2
$2.06M Buy
84,872
+935
+1% +$21.8K 0.99% 35
2025
Q1
$2.13M Buy
83,937
+55,823
+199% +$1.46M 1.06% 33
2024
Q4
$746K Sell
28,114
-46,223
-62% -$1.25M 0.35% 45
2024
Q3
$2.15M Buy
74,337
+492
+0.7% +$14.4K 0.97% 35
2024
Q2
$2.07M Buy
73,845
+8,195
+12% +$226K 1.09% 26
2024
Q1
$1.82M Buy
65,650
+55,630
+555% +$1.54M 0.94% 30
2023
Q4
$288K Buy
+10,020
New +$303K 0.19% 57

Other funds holding PFE

Optimist Retirement Group's PFE Position: Q2 2026 in Review

Optimist Retirement Group increased its Pfizer (PFE) stake by 0.33% in Q2 2026, buying an estimated $8.13K and bringing the position to 93,529 shares worth $2.25M. The position accounts for 0.87% of the portfolio, ranked #35.

Optimist Retirement Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.62M in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Optimist Retirement Group held 93,529 shares of Pfizer worth $2.25M as of Q2 2026.
  • Optimist Retirement Group bought 311 Pfizer shares in Q2 2026, an estimated $8.13K.
  • Pfizer made up 0.87% of Optimist Retirement Group's portfolio in Q2 2026, its #35 holding.
  • Optimist Retirement Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Optimist Retirement Group's Pfizer position peaked at $2.62M in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.